29/12/2009
Experts in nanotechnology, biotechnology and clinical practice will meet in Montpellier on 28 and 29 January 2010 to attend the "Clinical Applications of Nanotechnologies in the Field of Cancer" symposium.
This symposium has been organized by the three leading centers in cancer nanotechnology research in Southern Europe: the Institute for Bioengineering of Catalonia, the Cancéropôle Lyon Auvergne Rhône-Alpes, and the Cancéropôle Grand Sud-Ouest. The InnaBioSanté Foundation and the Spanish Nanomedicine Platform have also made outstanding contributions.
The objective of the symposium is to foster multidisciplinary collaboration, with particular emphasis on clinical translation. It aims to bring together experts in nanotechnology and clinical oncologists of these three different regions (Barcelona, Toulouse and Lyon) and to promote scientific exchange. Within the framework of the symposium, the Biopol'H Consortium and its will also be presented.
Attendance at the symposium is free but registration is required through their website at http://www.cancerogso-colloques.org/nanocancer-montpellier2010. The deadline for registration is January 18, 2010.
22/06/2010
KIMbcn and Biopol'H organized last thursday June 17th the first breakfast of Henry Chesbrough with managers of pharmaceutical companies. During the 
[+ photos]
17/05/2010
Manel Esteller, director of the program of Epigenetics and Cancer Biology of IDIBELL, has been awarded for a work that discovered a connection between
07/05/2010
Santiago Nofuentes, chief operating officer of Consorci Sanitari Integral - the Holistic Health Consortium – has presented the results of the
06/05/2010
A scientific study led by Genevieve Buckland and Carlos Alberto Gonzalez Svatetz from the Nutrition, Environment and Cancer Unit at ICO-IDIBELL has
03/05/2010
Ramon López - director of Consortium Biopol’H - and Santiago Nofuentes - chief executive officer of Consorci Sanitari Integral (Holistic
